C‐reactive protein as a prognostic predictor for non‐muscle invasive bladder cancer after intravesical bacillus Calmette‐Guérin therapy: A Japan Urological Oncology Group study analysis-Reference-Cited by-同舟云学术

C‐reactive protein as a prognostic predictor for non‐muscle invasive bladder cancer after intravesical bacillus Calmette‐Guérin therapy: A Japan Urological Oncology Group study analysis

Published:2022-11-30 Issue:3 Volume:30 Page:299-307
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Nishikawa Ryoma¹^ORCID,Miyake Makito²^ORCID,Morizane Shuichi¹,Shimizu Ryutaro¹,Teraoka Shogo¹,Honda Masashi¹^ORCID,Iida Kota²^ORCID,Nishimura Nobutaka²,Sazuka Tomokazu³^ORCID,Kimura Takahiro⁴,Ito Akihiro⁵,Shiga Kenichiro⁶,Taoka Rikiya⁷^ORCID,Kojima Takahiro⁸,Kobayashi Takashi⁹^ORCID,Nishiyama Naotaka¹⁰,Kitamura Hiroshi¹⁰,Nishiyama Hiroyuki¹¹,Fujimoto Kiyohide²^ORCID,Takenaka Atsushi¹

Affiliation:

1. Division of Urology, Department of Surgery Faculty of Medicine, Tottori University Tottori Yonago Japan

2. Department of Urology Nara Medical University Kashihara Nara Japan

3. Department of Urology Graduate School of Medicine, Chiba University Chiba Chiba City Japan

4. Department of Urology Jikei University School of Medicine Tokyo Minato‐ku Japan

5. Department of Urology Tohoku University Graduates School of Medicine Miyagi Sendai Japan

6. Department of Urology Harasanshin Hospital Fukuoka City Fukuoka Japan

7. Department of Urology, Faculty of Medicine Kagawa University Kita‐gun Kagawa Japan

8. Department of Urology Aichi Cancer Center Nagoya City Aichi Japan

9. Department of Urology Kyoto University Graduate School of Medicine Kyoto City Kyoto Japan

10. Department of Urology, Faculty of Medicine University of Toyama Toyama City Toyama Japan

11. Department of Urology, Faculty of Medicine University of Tsukuba Tsukuba City Ibaraki Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.15106

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old

3. Best practice in the treatment of nonmuscle invasive bladder cancer

4. Epidemiology and Risk Factors of Urothelial Bladder Cancer

5. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials